文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

嗜铬细胞瘤危象在ICU:法国多中心队列研究强调体外膜氧合作为挽救治疗

Pheochromocytoma Crisis in the ICU: A French Multicenter Cohort Study With Emphasis on Rescue Extracorporeal Membrane Oxygenation.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论嗜铬细胞瘤危象ICU病死率高,对不明原因心源性休克应常规考虑该诊断并做腹部CT,最重病例可考虑ECMO和肾上腺切除术。

这项法国15个ICU、16年回顾性多中心队列纳入34例嗜铬细胞瘤危象患者,中位年龄46岁,65%为男性,入ICU时中位SOFA评分8分、SAPS II 49.5分,左室射血分数中位30%。23例需机械通气(主要因充血性心力衰竭),23例(68%)使用血管活性药,8例(24%)行肾脏替代治疗,14例(41%)使用ECMO作为挽救治疗。33/34例通过CT诊断嗜铬细胞瘤,检测时尿甲氧基肾上腺素和儿茶酚胺水平均升高;5例急诊手术(其中2例在ECMO期间)。ICU总病死率24%(8/34),90天总病死率27%(9/34);ECMO组与非ECMO组粗90天病死率无显著差异(22% vs 30%,p=0.7),尽管ECMO组入ICU时严重度评分更高。作者认为,常规考虑该诊断并对不明原因心源性休克患者行腹部CT可能有助于更早诊断,最严重病例可考虑ECMO和肾上腺切除术作为治疗手段。

要点

  • 对不明原因心源性休克患者应常规考虑嗜铬细胞瘤危象并尽早行腹部CT,本队列33/34例经CT诊断。
  • 嗜铬细胞瘤危象入ICU时左室射血分数中位30%,常表现为充血性心力衰竭需机械通气(23例)。
  • ECMO作为挽救治疗用于14/34例(41%);ECMO组与非ECMO组粗90天病死率22% vs 30%,无显著差异(p=0.7)。
  • ICU总病死率24%(8/34),90天总病死率27%(9/34),提示该病危象病死率高。
  • 5例急诊手术(2例在ECMO期间),作者认为最严重病例可考虑ECMO和肾上腺切除术。

适用人群与场景

  • 法国15个大学与非大学ICU收治的嗜铬细胞瘤危象成人患者,中位年龄46岁(40-54岁),65%为男性。
  • 入ICU时中位SOFA评分8分(4-12),中位SAPS II评分49.5分(27-70)。

诊断标准与关键阈值

  • 嗜铬细胞瘤诊断:33/34例经CT诊断;检测时尿甲氧基肾上腺素和儿茶酚胺水平均升高。

处置流程与药物剂量

  • 机械通气用于23例,主要因充血性心力衰竭。
  • 血管活性药物用于23例(68%)。
  • 肾脏替代治疗用于8例(24%)。
  • ECMO作为挽救治疗用于14例(41%)。
  • 5例急诊手术,其中2例在ECMO期间。

红旗征与不能漏的情况

  • 不明原因心源性休克:作者认为应常规考虑嗜铬细胞瘤危象并行腹部CT以助早期诊断。

研究设计与关键结果

  • 研究类型:16年多中心回顾性队列研究,纳入34例嗜铬细胞瘤危象ICU患者。
  • 主要结果:ICU病死率24%(8/34),90天病死率27%(9/34)。
  • ECMO组与非ECMO组粗90天病死率22% vs 30%,无显著差异(p=0.7),尽管ECMO组入ICU时严重度评分更高。
  • 左室射血分数中位30%(15-40%)。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对不明原因心源性休克患者应常规考虑嗜铬细胞瘤危象并做腹部CT,可能有助于更早诊断(作者结论)。
  • 作者认为,ECMO和肾上腺切除术可作为最严重病例的治疗考虑。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To describe the characteristics, management, and outcome of patients admitted to ICUs for pheochromocytoma crisis.

DESIGN: A 16-year multicenter retrospective study.

SETTING: Fifteen university and nonuniversity ICUs in France.

PATIENTS: Patients admitted in ICU for pheochromocytoma crisis.

INTERVENTIONS: None.

MEASUREMENT AND MAIN RESULTS: We included 34 patients with a median age of 46 years (40-54 yr); 65% were males. At admission, the median Sequential Organ Failure Assessment score was 8 (4-12) and median Simplified Acute Physiology Score II 49.5 (27-70). The left ventricular ejection fraction was consistently decreased with a median value of 30% (15-40%). Mechanical ventilation was required in 23 patients, mainly because of congestive heart failure. Vasoactive drugs were used in 23 patients (68%) and renal replacement therapy in eight patients (24%). Extracorporeal membrane oxygenation was used as a rescue therapy in 14 patients (41%). Pheochromocytoma was diagnosed by CT in 33 of 34 patients. When assayed, urinary metanephrine and catecholamine levels were consistently elevated. Five patients underwent urgent surgery, including two during extracorporeal membrane oxygenation. Overall ICU mortality was 24% (8/34), and overall 90-day mortality was 27% (9/34). Crude 90-day mortality was not significantly different between patients managed with versus without extracorporeal membrane oxygenation (22% vs 30%) (p = 0.7) despite higher severity scores at admission in the extracorporeal membrane oxygenation group.

CONCLUSIONS: Mortality is high in pheochromocytoma crisis. Routinely considering this diagnosis and performing abdominal CT in patients with unexplained cardiogenic shock may allow an earlier diagnosis. Extracorporeal membrane oxygenation and adrenalectomy should be considered as a therapeutic in most severe cases.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Sauneuf B, Chudeau N, Champigneulle B, et al. Pheochromocytoma Crisis in the ICU: A French Multicenter Cohort Study With Emphasis on Rescue Extracorporeal Membrane Oxygenation. Crit Care Med. 2017. PMID: 28403121. doi:10.1097/CCM.0000000000002333

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。